UniProtKB/SwissProt variant VAR

Variant information

Variant position:

12

The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:

LB/B

The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Lysine (K) to Glutamate (E) at position 12 (K12E, p.Lys12Glu).

Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:

Change from large size and basic (K) to medium size and acidic (E)

The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:

1

The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page

Variant description:

In Anantharaj.

Any additional useful information about the variant.

Other resources:

Links to websites of interest for the variant.

Variant rs33938574 [ dbSNP | Ensembl ]

Sequence information

Variant position:

12

The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:

142

The length of the canonical sequence.

Location on the sequence:

MVLSPADKTNV K AAWGKVGAHAGEYGAEALER

The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         MVLSPADKTNVKAAWGKVGAHAGEYGAEALER

Gorilla                       -VLSPADKTNVKAAWGKVGAHAGDYGAEALER

                              -VLSPADKTNIKSTWDKIGGHAGDYGGEALDR

Rhesus macaque                MVLSPADKSNVKAAWGKVGGHAGEYGAEALER

Chimpanzee                    MVLSPADKTNVKAAWGKVGAHAGEYGAEALER

Mouse                         MVLSGEDKSNIKAAWGKIGGHGAEYGAEALER

Rat                           MVLSADDKTNIKNCWGKIGGHGGEYGEEALQR

Pig                           -VLSAADKANVKAAWGKVGGQAGAHGAEALER

Bovine                        MVLSAADKGNVKAAWGKVGGHAAEYGAEALER

Rabbit                        MVLSPADKTNIKTAWEKIGSHGGEYGAEAVER

Sheep                         MVLSAADKSNVKAAWGKVGGNAGAYGAEALER

Cat                           -VLSAADKSNVKACWGKIGSHAGEYGAEALER

Horse                         MVLSAADKTNVKAAWSKVGGHAGEYGAEALER

Chicken                       MVLSAADKNNVKGIFTKIAGHAEEYGAETLER

Xenopus tropicalis            MHLTADDKKHIKAIWPSVAAHGDKYGGEALHR

Zebrafish                     MSLSDTDKAVVKAIWAKISPKADEIGAEALAR

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Initiator methionine	1 – 1	Removed
Chain	2 – 142	Hemoglobin subunit alpha
Site	12 – 12	Not glycated
Modified residue	4 – 4	Phosphoserine
Modified residue	8 – 8	N6-succinyllysine; alternate
Modified residue	9 – 9	Phosphothreonine
Modified residue	12 – 12	N6-succinyllysine
Modified residue	17 – 17	N6-acetyllysine; alternate
Modified residue	17 – 17	N6-succinyllysine; alternate
Modified residue	25 – 25	Phosphotyrosine
Glycosylation	8 – 8	N-linked (Glc) (glycation) lysine; alternate
Glycosylation	17 – 17	N-linked (Glc) (glycation) lysine; alternate
Helix	5 – 18

Literature citations

A case of HB J-Meerut (or Hb J-Birmingham) [alpha 120(H3)Ala-->Glu].
Yalcin A.; Avcu F.; Beyan C.; Guergey A.; Ural A.U.;
Hemoglobin 18:433-435(1994)
Cited for: VARIANT J-MEERUT/J-BIRMINGHAM GLU-121;

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P69905: Variant p.Lys12Glu